Life-Sciences-USA.com
The Transatlantic Life Sciences Web Portal

This is a free web portal for the life sciences in North America, Europe and Israel... » read more

Centogene & Insilico Medicine: AI-based NPC Target Discovery (2022-01-20)
> CENTOGENE and Insilico Medicine will work together to identify, rank, and annotate proteins to identify novel therapeutic targets for NPC using AI > NPC is a rare genetic disease occurring in approximately 1 in 120,000 live births, with many cases going mis- o...
Prolight Diagnostics Acquires Psyros Diagnostics for £5.25m (2022-01-20)
UK-based Psyros Diagnostics Ltd has today signed an agreement to be acquired for 65 MSEK (ca. £5.25M) by the Swedish company Prolight Diagnostics AB. Psyros Diagnostics has developed a ground-breaking single-molecule counting Point-of-Care (POC) technology. This pa...
DefiniGen Promotes Chris Kirton to CEO (2022-01-20)
DefiniGEN is pleased to announce the appointment of Dr Chris Kirton as Chief Executive Officer. Chris has more than 16 years of operational experience and joined DefiniGEN as Chief Operating Officer in June 2020. The appointment is key for DefiniGEN as they expand ...
Bruker Acquires Swiss-based Prolab Instruments GmbH (2022-01-19)
Prolab precision pumps, autosamplers and nano-flow to cap-LC UHPLC systems to further enhance performance and robustness of timsTOF 4D proteomics and metabolomics solutions > Unique Zirconium™ nano-LC to cap-LC pump technology for 4 nL/min to 10 µL/min flow rate...
64x Bio Raises $55m Series A Led by Lifeforce Capital (2022-01-19)
> Multibillion-dollar gene therapy market facing critical manufacturing bottleneck that limits reach of lifesaving therapies to patients > VectorSelect™ platform has the potential to revolutionize the economics and accessibility of gene therapy. 64x Bio, a ...
Altos Labs Launches with $3b & Stellar Management Team (2022-01-19)
- Altos will be a community of leading scientists, clinicians, and leaders from both academia and industry working together towards a common mission - Altos initially based in the San Francisco Bay Area, San Diego, and in Cambridge, UK, with significant collabor...
UCB to Acquire Zogenix for up to $1.9b (2022-01-19)
> Transaction broadens and builds upon UCB’s role as a leader in, and our continued commitment to, addressing unmet needs of people living with epilepsy, complementing existing medicines and expanding clinical development pipeline of epilepsy and rare disease thera...
Inova, Backed by Carlyle, Acquires Labiotech.eu (2022-01-18)
Inova, the leading biopharma partnering platform, has acquired Labiotech, an independent news media covering European biotech innovation. This acquisition follows a €60 million investment from global investment firm Carlyle (NASDAQ: CG) in 2021 and reaffirms the st...
Bruker Acquires Majority Share in PreOmics GmbH (2022-01-18)
PreOmics Offers Unique Technologies, Advanced Automation Solutions and High-Performance Consumables for the Homogenization, Enrichment and Sample Preparation of Biopsy, Tissue, Cell Line and Plasma Samples in Unbiased, Deep Proteomics for Biopharma and Clinical Res...
Ori Biotech Raises over $100m in Series B Funding (2022-01-18)
Funds will allow for a rapid transition through pre-commercialization to market launch Ori Biotech Ltd. (Ori), a leader in cell and gene therapy (CGT) manufacturing technology, today announces it has secured over $100 million in an oversubscribed Series B fund...

Life-Sciences-USA.com is your doorway to the Transatlantic life sciences!

[LSUS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the North America, Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUS] is 100% Made in Germany!

» Start here with the latest News!

Picture [iito] Plain Stupid Simple 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]